キャリアスクリーニング市場：タイプ別、病状別、技術別、エンドユーザー別-2025～2030年の世界予測

キャリアスクリーニング市場は、2023年に30億7,000万米ドルと評価され、2024年には35億2,000万米ドルに達すると予測され、CAGR 14.93％で成長し、2030年には81億3,000万米ドルになると予測されています。

キャリアスクリーニングは、個人が子孫に遺伝する可能性のある特定の遺伝子変異の保因者であるかどうかを判定するために使用される遺伝子検査法です。常染色体劣性遺伝性疾患やX連鎖性遺伝性疾患の保因者を特定し、家族計画に不可欠な情報を記載しています。キャリアスクリーニングの必要性は、遺伝性疾患のトランスミッションを予防する可能性から生じ、予防医療と生殖計画において不可欠なツールとなります。妊娠前や出生前の状況において、これから親になる人たちが十分な情報を得た上で生殖に関する選択をするのに役立ちます。最終用途は主に病院、診断ラボ、個人クリニックです。

キャリアスクリーニング市場は主に、遺伝性疾患に対する意識の高まり、遺伝子検査技術の進歩、遺伝性疾患の有病率の上昇によって牽引されています。主要成長要因としては、遺伝子変異のより広範で正確な分析を提供する次世代シーケンシング（NGS）技術の統合が挙げられます。遠隔医療と在宅検査キットの拡大は新たな機会を提供し、ユーザーにとってより幅広いアクセスと利便性を可能にします。企業は、こうした機会を活用するために、戦略的提携への投資や検査のコスト効率の改善を検討すべきです。

しかし、同市場は検査費用の高騰、倫理的配慮、規制上の課題といった制約に直面しています。偽陽性や偽陰性の可能性は、予期せぬ倫理的ジレンマを引き起こし、市場成長に影響を与える可能性があります。さらに、検査結果を受けて遺伝カウンセリングを受ける必要があるため、複雑さとコストが増大します。技術革新を促進するためには、より安価なスクリーニング技術の開発、検査精度の向上、消費者参加型の使いやすいインターフェースの強化に注力することが重要です。遺伝子治療や編集技術CRISPRの研究も、将来の成長への道筋を示す可能性があります。キャリアスクリーニング市場の性質はダイナミックで進化しており、急速な技術進歩と規制開拓によって特徴づけられます。潜在的なユーザーの認識と受容を高めるための患者教育イニシアティブに投資することで、事業の成長を強化することができます。

市場力学：急速に進化するキャリアスクリーニング市場の主要市場洞察を公開

キャリアスクリーニング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 遺伝性疾患の有病率の高まりと早期発見・予防への注力
  • 高齢者の増加と染色体異常の高いリスク
  • 医療インフラへの投資の増加と遺伝性疾患の管理に対する政府の取り組み
• 市場抑制要因
  • 熟練した専門家と専門サービスの不足
• 市場機会
  • POC診断における新たな改善
  • キャリアスクリーニングにおける技術の進歩
• 市場課題
  • 統一されていない基準やガイドラインの存在

ポーターのファイブフォース：キャリアスクリーニング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、キャリアスクリーニング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：キャリアスクリーニング市場における外部からの影響の把握

外部マクロ環境要因は、キャリアスクリーニング市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：キャリアスクリーニング市場における競合情勢の把握

キャリアスクリーニング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：キャリアスクリーニング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、キャリアスクリーニング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：キャリアスクリーニング市場における成功への道筋を描く

キャリアスクリーニング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 遺伝性疾患の増加と早期発見・予防への重点
    • 高齢化人口の増加と染色体異常の高リスク
    • 遺伝性疾患の管理のための医療インフラと政府の取り組みへの投資の増加
  • 抑制要因
    • 熟練した専門家と専門サービスの不足
  • 機会
    • POC診断における新たな改善
    • キャリアスクリーニングにおける技術的進歩
  • 課題
    • 統一されていない基準やガイドラインの存在
• 市場セグメンテーション分析
  • タイプ：拡大キャリアスクリーニング（ECS）は、遺伝的健康と状態に関する幅広い概要を提供
  • エンドユーザー：病院におけるキャリアスクリーニングの応用の進化
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 キャリアスクリーニング市場：タイプ別

• イントロダクション
• 拡大型キャリアスクリーニング
  • カスタマイズ型パネルテスト
  • 事前設計型パネルテスト
• 対象疾患キャリアスクリーニング

第7章 キャリアスクリーニング市場：病状別

• イントロダクション
• 血液疾患
• 神経疾患
• 肺疾患

第8章 キャリアスクリーニング市場：技術別

• イントロダクション
• DNA配列分析
• マイクロアレイ
• ポリメラーゼ連鎖反応

第9章 キャリアスクリーニング市場：エンドユーザー別

• イントロダクション
• 病院
• 医院とクリニック
• リファレンスラボ

第10章 南北アメリカのキャリアスクリーニング市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のキャリアスクリーニング市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのキャリアスクリーニング市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Invitae、生殖医療資産のNateraへの売却を完了
  • Fulgent Geneticsが新しいBeacon787拡大キャリアスクリーニングパネルを発表
  • Bio-TechneとOxford Nanopore Technologiesが提携し、革新的な生殖医療とキャリアスクリーニングソリューションを市場に投入
• 戦略分析と提言

企業一覧

• 23Andme Inc.
• Abbott Laboratories
• Ambry Genetics Corporation by Konica Minolta, Inc.
• Asper Biogene
• Autogenomics Inc. by Prescient Medicine Holdings Inc.
• BGI Genomics Co., Ltd.
• Biora Therapeutics, Inc.
• CENTOGENE N.V.
• Danaher Corporation
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Fulgent Genetics, Inc.
• Gene by Gene, Ltd. by myDNA Inc.
• GeneDx Holdings Corp.
• Illumina Inc.
• Invitae Corporation
• Laboratory Corporation of America Holdings
• Luminex Corporation by DiaSorin Company
• MedGenome Labs Ltd.
• Myriad Genetics, Inc.
• Natera, Inc.
• OPKO Health, Inc.
• Otogenetics Corporation
• Quest Diagnostics Inc.
• Thermo Fisher Scientific Inc.
• TRUE HEALTH LABS

LIST OF FIGURES

• FIGURE 1. CARRIER SCREENING MARKET RESEARCH PROCESS
• FIGURE 2. CARRIER SCREENING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARRIER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. CARRIER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. CARRIER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARRIER SCREENING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARRIER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CARRIER SCREENING MARKET DYNAMICS
• TABLE 7. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CARRIER SCREENING MARKET SIZE, BY CUSTOMIZED PANEL TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CARRIER SCREENING MARKET SIZE, BY PREDESIGNED PANEL TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CARRIER SCREENING MARKET SIZE, BY TARGETED DISEASE CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CARRIER SCREENING MARKET SIZE, BY HEMATOLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CARRIER SCREENING MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CARRIER SCREENING MARKET SIZE, BY PULMONARY CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CARRIER SCREENING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CARRIER SCREENING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CARRIER SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CARRIER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CARRIER SCREENING MARKET SIZE, BY PHYSICIAN OFFICES & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CARRIER SCREENING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 43. CANADA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. CANADA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. CHINA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 70. CHINA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 71. CHINA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. CHINA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. INDIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. INDIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 75. INDIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 76. INDIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. INDIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. ITALY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ITALY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 161. ITALY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 162. ITALY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. ITALY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. POLAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. POLAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 181. POLAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 182. POLAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. POLAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. QATAR CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. QATAR CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 186. QATAR CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 187. QATAR CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. QATAR CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. CARRIER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 235. CARRIER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

The Carrier Screening Market was valued at USD 3.07 billion in 2023, expected to reach USD 3.52 billion in 2024, and is projected to grow at a CAGR of 14.93%, to USD 8.13 billion by 2030.

Carrier screening is a genetic testing procedure used to determine if an individual is a carrier of a specific genetic mutation that could potentially be passed on to their offspring. Its scope extends to identifying carriers of autosomal recessive and X-linked genetic disorders, providing vital information for family planning. The necessity of carrier screening arises from its potential to prevent the transmission of genetic disorders, making it an essential tool in preventive healthcare and reproductive planning. It finds applications in pre-pregnancy and prenatal contexts, aiding prospective parents in making informed reproductive choices. The end-use scope primarily involves hospitals, diagnostic laboratories, and private clinics.

The market for carrier screening is primarily driven by increasing awareness of genetic disorders, advancements in genetic testing technologies, and the rising prevalence of genetic conditions. Key growth factors include the integration of next-generation sequencing (NGS) technologies that offer a broader and more accurate analysis of genetic mutations. The expansion of telehealth and at-home testing kits provides new opportunities, enabling wider accessibility and convenience for users. Companies should consider investing in strategic collaborations and improving the cost-efficiency of tests to tap into these opportunities.

However, the market faces limitations such as high costs of testing, ethical considerations, and regulatory challenges. The potential of false positives or negatives can result in unforeseen ethical dilemmas, impacting market growth. Moreover, the need for genetic counseling following test results adds to the complexity and cost. To foster innovation, focusing on developing more affordable screening technologies, improving test accuracy, and enhancing user-friendly interfaces for consumer engagement is crucial. Researching into gene therapy and editing techniques CRISPR could also provide pathways for future growth. The nature of the carrier screening market is dynamic and evolving, characterized by rapid technological advancements and regulatory developments. Business growth can be bolstered by investing in patient education initiatives to enhance awareness and acceptance among potential users.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Carrier Screening Market

The Carrier Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of inherited diseases and focus on early disease detection and prevention
  • Rising geriatric population and high risk of chromosomal abnormalities
  • Increasing investment in healthcare infrastructure and government initiatives for the management of genetic disorders
• Market Restraints
  • Dearth of skilled professionals and professional services
• Market Opportunities
  • Emerging improvements in POC diagnostics
  • Technological advancements in carrier screening
• Market Challenges
  • Presence of non-uniform standards and guidelines

Porter's Five Forces: A Strategic Tool for Navigating the Carrier Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Carrier Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Carrier Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Carrier Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Carrier Screening Market

A detailed market share analysis in the Carrier Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Carrier Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Carrier Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Carrier Screening Market

A strategic analysis of the Carrier Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Carrier Screening Market, highlighting leading vendors and their innovative profiles. These include 23Andme Inc., Abbott Laboratories, Ambry Genetics Corporation by Konica Minolta, Inc., Asper Biogene, Autogenomics Inc. by Prescient Medicine Holdings Inc., BGI Genomics Co., Ltd., Biora Therapeutics, Inc., CENTOGENE N.V., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Gene by Gene, Ltd. by myDNA Inc., GeneDx Holdings Corp., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation by DiaSorin Company, MedGenome Labs Ltd., Myriad Genetics, Inc., Natera, Inc., OPKO Health, Inc., Otogenetics Corporation, Quest Diagnostics Inc., Thermo Fisher Scientific Inc., and TRUE HEALTH LABS.

Market Segmentation & Coverage

This research report categorizes the Carrier Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Expanded Carrier Screening and Targeted Disease Carrier Screening. The Expanded Carrier Screening is further studied across Customized Panel Testing and Predesigned Panel Testing.
• Based on Medical Condition, market is studied across Hematological Conditions, Neurological Conditions, and Pulmonary Conditions.
• Based on Technology, market is studied across DNA Sequencing, Microarrays, and Polymerase Chain Reaction.
• Based on End-User, market is studied across Hospitals, Physician Offices & Clinics, and Reference Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of inherited diseases and focus on early disease detection and prevention
    • 5.1.1.2. Rising geriatric population and high risk of chromosomal abnormalities
    • 5.1.1.3. Increasing investment in healthcare infrastructure and government initiatives for the management of genetic disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Dearth of skilled professionals and professional services
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging improvements in POC diagnostics
    • 5.1.3.2. Technological advancements in carrier screening
  • 5.1.4. Challenges
    • 5.1.4.1. Presence of non-uniform standards and guidelines
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Expanded carrier screening (ECS) offers a wide overview of genetic health and conditions
  • 5.2.2. End-User: Evolving application of carrier screening in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Carrier Screening Market, by Type

• 6.1. Introduction
• 6.2. Expanded Carrier Screening
  • 6.2.1. Customized Panel Testing
  • 6.2.2. Predesigned Panel Testing
• 6.3. Targeted Disease Carrier Screening

7. Carrier Screening Market, by Medical Condition

• 7.1. Introduction
• 7.2. Hematological Conditions
• 7.3. Neurological Conditions
• 7.4. Pulmonary Conditions

8. Carrier Screening Market, by Technology

• 8.1. Introduction
• 8.2. DNA Sequencing
• 8.3. Microarrays
• 8.4. Polymerase Chain Reaction

9. Carrier Screening Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Physician Offices & Clinics
• 9.4. Reference Laboratories

10. Americas Carrier Screening Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Carrier Screening Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Carrier Screening Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Invitae Completes Sale of Reproductive Health Assets to Natera
  • 13.3.2. Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
  • 13.3.3. Bio-Techne and Oxford Nanopore Technologies Partner to Bring Innovative Reproductive Health and Carrier Screening Solutions to the Market
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 23Andme Inc.
• 2. Abbott Laboratories
• 3. Ambry Genetics Corporation by Konica Minolta, Inc.
• 4. Asper Biogene
• 5. Autogenomics Inc. by Prescient Medicine Holdings Inc.
• 6. BGI Genomics Co., Ltd.
• 7. Biora Therapeutics, Inc.
• 8. CENTOGENE N.V.
• 9. Danaher Corporation
• 10. Eurofins Scientific
• 11. F. Hoffmann-La Roche Ltd.
• 12. Fulgent Genetics, Inc.
• 13. Gene by Gene, Ltd. by myDNA Inc.
• 14. GeneDx Holdings Corp.
• 15. Illumina Inc.
• 16. Invitae Corporation
• 17. Laboratory Corporation of America Holdings
• 18. Luminex Corporation by DiaSorin Company
• 19. MedGenome Labs Ltd.
• 20. Myriad Genetics, Inc.
• 21. Natera, Inc.
• 22. OPKO Health, Inc.
• 23. Otogenetics Corporation
• 24. Quest Diagnostics Inc.
• 25. Thermo Fisher Scientific Inc.
• 26. TRUE HEALTH LABS